Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2007
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cellsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Biochemical Pharmacology|March 24, 2004
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNACarlo Mischiati, Alessia Finotti, Alessia Sereni, et al.
Bioorganic & Medicinal Chemistry|June 24, 2004
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studiesPier Giovanni Baraldi, Italo Beria, Paolo Cozzi, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2010
Symmetrical alpha-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluationRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Bioorganic & Medicinal Chemistry|February 14, 2012
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammationPier Giovanni Baraldi, Romeo Romagnoli, Giulia Saponaro, et al.
Journal of Medicinal Chemistry|July 8, 2005
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|July 22, 2005
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylationRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2007
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cellsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Biochemical Pharmacology|March 24, 2004
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNACarlo Mischiati, Alessia Finotti, Alessia Sereni, et al.
Bioorganic & Medicinal Chemistry|June 24, 2004
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studiesPier Giovanni Baraldi, Italo Beria, Paolo Cozzi, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2010
Symmetrical alpha-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluationRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Bioorganic & Medicinal Chemistry|February 14, 2012
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammationPier Giovanni Baraldi, Romeo Romagnoli, Giulia Saponaro, et al.
Journal of Medicinal Chemistry|July 8, 2005
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|July 22, 2005
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylationRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
Pageof 16